ILS Drug Delivery SRF Vacancy 2020 October

Bhubaneswar 751023

Advt. No. 08/2020 

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from Indian Nationals to join in the following position. 

Senior Research Fellow

Project title: DBT Funded project “Development of protein hydrogels for targeted drug delivery” 

Fellowship: Rs. 35000/- + HRA@16% 

Eligibility: Masters in Chemistry, Biotechnology or Allied branches and having secured 60% aggregate marks (50% for OBC/ST/SC) with 2 years of research experience are eligible to apply. 

Preference will be given to candidates having NET-JRF/NET-LS/GATE qualification. For non-NET/GATE candidates, guidelines stipulated by DST will be applicable. 

Age Limit: The upper age limit of the candidate should be below 32 years as on last date of receipt of application. Age relaxation will be given to the candidates as per Govt. of India rules. 

Selection will be carried out through application screening, followed by an interview process. 

Interested/eligible candidates may download the application form from the institute website ( and apply along with self-attested copies of mark sheets, certificates and experience details to “The Director, Institute of Life Sciences, Nalco Square, Bhubaneswar-751023”. Superscribe the envelope with "Advt. no. / Date & Application for the position of Senior Research Fellow” No TA/DA will be paid for attending the interview. The decision of the Director regarding the selection of candidates will be final and no further correspondence will be entertained in this regard. 

1. Last date for receiving an application: 10.11.2020 
2. Date of display of shortlisted candidates in ILS website: 13.11.2020 
3. Date & time of interview: will be notified on the website 

Note: All communication will be through e-mail. No separate call letter will be issued to the candidates. 

Application form

To Get All Updates from helpBIOTECH, Subscribe Now by Email

Post a comment